Current Affairs In Detail

ICMR validates Truenat beta CoV test for COVID-19 screening tests
ICMR validates Truenat beta CoV test for COVID-19 screening tests

The revised strategy ICMR stated that asymptomatic direct and high-risk contacts of a confirmed case should be tested once between the fifth and fourteenth day of coming in his/her contact.

10 April 2020 Current Affairs:The Indian Council of Medical Research (ICMR) validated the Truenat beta CoV test, a tuberculosis testing machine for COVID-19 screening tests. The ICMR had updated its testing strategy for COVID-19. 

Truenat beta CoV test:
♦ The revised strategy ICMR stated that asymptomatic direct and high-risk contacts of a confirmed case should be tested once between the fifth and fourteenth day of coming in his/her contact.
♦ ICMR has validated the Truenat beta CoV test on the Truelab workstation. It has recommended it as a screening test.
♦ Under the test, the throat/nasal swabs will be collected in the viral transport medium (VTM) with virus lysis buffer provided along with the kit.
♦ Previous studies have shown that virus lysis buffer neutralizes Nipah and H1N1 viruses. The results of the stability of viral RNA after neutralization of SARS-CoV-2 by virus lysis buffer are awaited from ICMR-NIV, Pune. Until then, Truenat beta CoV test should only be performed with all biosafety precautions in BSL-2 or BSL-3 setups at laboratories.